nalidixic acid has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lawrence, JW | 1 |
| Darkin-Rattray, S | 1 |
| Xie, F | 1 |
| Neims, AH | 1 |
| Rowe, TC | 1 |
| Kim, YS | 1 |
| Kim, KM | 1 |
| Song, R | 1 |
| Jun, MJ | 1 |
| Sohn, YS | 1 |
2 other studies available for nalidixic acid and Leukemia L 1210
| Article | Year |
|---|---|
4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells.
Topics: Animals; Anti-Infective Agents; Cell Division; Ciprofloxacin; DNA, Mitochondrial; DNA, Neoplasm; Lac | 1993 |
Synthesis, characterization and antitumor activity of quinolone-platinum(II) conjugates.
Topics: Animals; Antineoplastic Agents; Carboplatin; Fluoroquinolones; Leukemia L1210; Magnetic Resonance Sp | 2001 |